Caldwell Sutter Capital, Inc. Celldex Therapeutics, Inc. Call Options Transaction History
Caldwell Sutter Capital, Inc.
- $215 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CLDX
# of Institutions
198Shares Held
63.8MCall Options Held
212KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$213 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$124 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$98.5 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$89.3 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$87.6 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.23B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...